SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
A funding to expand operations and provide better patient care
Proposed combination enhances Pfizer’s position as a leading company in oncology
Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Plantasens Pro LM is 100% natural, readily biodegradable, COSMOS and Natrue certified
Subscribe To Our Newsletter & Stay Updated
